2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents-Reference-Cited by-同舟云学术

2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents

Published:2005-01 Issue:1 Volume:15 Page:51-55
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Martín José A.,Brooks Dawn A.,Prieto Lourdes,González Rosario,Torrado Alicia,Rojo Isabel,López de Uralde Beatriz,Lamas Carlos,Ferritto Rafael,Dolores Martín-Ortega María,Agejas Javier,Parra Francisco,Rizzo John R.,Rhodes Gary A.,Robey Roger L.,Alt Charles A.,Wendel Samuel R.,Zhang Tony Y.,Reifel-Miller Anne,Montrose-Rafizadeh Chahrzad,Brozinick Joseph T.,Hawkins Eric,Misener Elizabeth A.,Briere Daniel A.,Ardecky Robert,Fraser James D.,Warshawsky Alan M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference50 articles.

1. Progress in Drug research;Turner,1998

2. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

3. Insulin resistance - how important is it to treat?

4. Insulin resistance in noninsulin-dependent diabetes mellitus: Impact of sulfonylurea agents in vivo and in vitro

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin sensitizers in 2023: lessons learned and new avenues for investigation;Expert Opinion on Investigational Drugs;2023-09-02

2. A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents;European Journal of Medicinal Chemistry Reports;2022-08

3. Mechanisms and Characteristics of Sulfonylureas and Glinides;Current Topics in Medicinal Chemistry;2020-01-22

4. Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis;ACS Medicinal Chemistry Letters;2019-06-24

5. PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development;Bioorganic & Medicinal Chemistry;2018-12